Prognia
Drug Database
🇪🇺EU · EMAWithdrawnATC: J07BB03

Fluenz Tetra(A/Darwin/9/2021 (H3N2) - like strain (A/Norway/16606/2021, MEDI 355293) / A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/1/2020, MEDI 340505) / B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, MEDI 355292) / B/Phuket/3073/2013 - like strain (B/Phuket/3073/2013, MEDI 306444))

Influenza, Human

Marketing Authorisation Holder: AstraZeneca AB

EMA Authorisation: 04/12/2013

INN: influenza vaccine (live attenuated, nasal)

Indication

Prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. The use of Fluenz Tetra should be based on official recommendations.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Fluenz Tetra — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Ask about Fluenz TetraCreate Free Account

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.